Cryoport (CYRX) Research & Development (2010 - 2026)

Cryoport (CYRX) has 17 years of Research & Development data on file, last reported at $3.9 million in Q1 2026.

• Research & Development for Q1 2026 came in at $3.9 million, down 0.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.0 million (up 0.72% YoY), and the FY2025 annual result was $17.0 million, down 3.78% from the prior year.
• Research & Development slipped to $3.9 million in Q1 2026 per CYRX's latest filing, from $4.5 million in the prior quarter.
• Over five years, Research & Development peaked at $5.2 million in Q3 2023 and troughed at $3.5 million in Q2 2022.
• A 5-year average of $4.3 million and a median of $4.2 million in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2022 and 2023: Research & Development decreased 21.07% in 2022, then advanced 29.28% in 2023.
• A 5-year view of Research & Development shows it stood at $4.7 million in 2022, then increased by 1.54% to $4.7 million in 2023, then declined by 12.51% to $4.2 million in 2024, then grew by 7.48% to $4.5 million in 2025, then retreated by 12.52% to $3.9 million in 2026.
• Business Quant data shows CYRX's Research & Development at $3.9 million in Q1 2026, $4.5 million in Q4 2025, and $4.5 million in Q3 2025.